Proper expression of the O-antigen of lipopolysaccharide is essential for the virulence of Yersinia enterocolitica O:8 in experimental oral infection of rabbits

FEMS Immunology and Medical Microbiology

Volumn 38, Issue 2, 2003, Pages 97-106

  Najdenski, H ^a   Golkocheva, E ^a   Vesselinova, A ^a   Bengoechea, J A ^b,c   Skurnik, M ^b  

^a INSTITUTE OF MICROBIOLOGY   (Bulgaria)

^b UNIVERSITY OF TURKU   (Finland)

^c HOSPITAL SON DURETA   (Spain)

Author keywords

Infection; Lipopolysaccharide; Mutant; Rabbit; Yersinia enterocolitica

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; O ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; BACTERIUM MUTANT; BIOSYNTHESIS; CONFERENCE PAPER; CONTROLLED STUDY; EXPERIMENTAL INFECTION; MOUTH INFECTION; NEUTROPHIL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RABBIT; SEROTYPE; STRAIN DIFFERENCE; WILD TYPE; YERSINIA ENTEROCOLITICA;

EID: 0038182852     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(03)00183-4     Document Type: Conference Paper

References (37)

1. Autenrieth I.B., Beer M., Bohn E., Kaufmann S.H.E., Heesemann J. Immune responses to Yersinia enterocolitica in susceptible BALB/c and resistant C57BL/ 6 mice: an essential role for gamma interferon. Infect. Immun. 62:1994;2590-2599.
2. Cardenas L., Clements J.D. Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens. Clin. Microbiol. Rev. 5:1992;328-342.
3. Pan Z.K., Ikonomidis G., Lazenby A., Pardoll D., Paterson Y. A recombinant Listeria monocytogenes vaccine expressing a model tumor antigen protects mice against lethal tumor cell challenge and causes regression of established tumors. Nat. Med. 1:1995;471-477.
4. Aldovini A., Young R.A. Humoral and cell mediated immune responses to live recombinant BCG-HIV vaccines. Nature. 351:1991;479-482.
5. Lüderitz, O., Westphal, O., Staube, A.M. and Nikaido, H. (1971) Isolation and chemical and immunological characterization of bacterial lipopolysaccharides. In: Microbial toxins (Weinbaum, S. Kadis and Ajl, S.J.), Vol.4, Academic Press, London.
6. Morrison D.C., Ryan J.L. Endotoxins and disease mechanisms. Annu. Rev. Med. 38:1987;417-432.
7. Mäkela P.H., Hovi M., Saxen H., Valtonen M., Valtonen V. Salmonella, complement, and mouse macrophages. Immunol. Lett. 19:1988;217-222.
8. Porat R., Johns M.A., McCabe W.R. Selective pressures and lipopolysaccharide subunits as determinants of resistance of clinical isolates of Gram-negative bacilli to human serum. Infect. Immun. 55:1987;320-328.
9. Engels W., Endert J., Kamps M.A.F., Van Boven C.P.A. Role of lipopolysaccharide in opsonization and phagocytosis of Pseudomonas aeruginosa. Infect. Immun. 49:1985;182-189.
10. Al-Hendy A., Toivanen P., Skurnik M. Lipopolysacharide O side chain of Yersinia enterocolitica O:3 is an essential virulence factor in an orally infected murine model. Infect. Immun. 60:1992;870-875.
11. Zhang L., Radziejewska-Lebrecht J., Krajewska-Pietrasik D., Toivanen P., Skurnik M. Molecular and chemical characterization of the lipopolysaccharide O-chain biosynthesis of Yersinia enterocolitica serotype O:8 and role of O-chain in virulence. Mol. Microbiol. 23:1997;63-76.
12. Bengoechea J.A., Pinta E., Oertelt C., Holst O., Radziejewska-Lebrecht J., Piotrowska-Seget Z., Venho R., Skurnik M. Functional characterization of Gne (UDP-N-acetylglucosamine-4-epimerase, EC 5.1.3.7), Wzz (chain length determinant) and Wzy (O-antigen polymerase) of Yersinia enterocolitica serotype O:8. J. Bacteriol. 184:2002;4277-4287.
13. Saint-Marie G. A paraffin embedding technique for studies employing immunofluorescence. J. Histochem. Cytochem. 1962;250-256.
14. Skurnik M., El Tahir Y., Saarinen M., Jalkanen S., Toivanen P. YadA mediates specific binding of enteropathogenic Yersinia enterocolitica to human intestinal submucosa. Infect. Immun. 62:1994;1252-1261.
15. Vissar L.G., Annema A., van Furth R. Role of Yops in inhibition of phagocytosis and killing of opsonized Yersinia enterocolitica by human granulocytes. Infect. Immun. 63:1995;2570-2575.
16. Pai C.H., De Stephano L. Serum resistance associated with virulence in Yersinia enterocolitica. Infect. Immun. 35:1982;605-611.
17. Vesselinova, A. (1984) Immunomorphologic studies of pigs experimentally infected with two vaccinal strains of the pseudorabies virus. 11th Conference of the O.I.E. Regional Commission for Europe, Vienna, 25-28 September, pp. 361-367.
18. Une T. Studies on the pathogenicity of Yersinia enterocolitica: I. Experimental infection in rabbits. Microbiol. Immunol. 21:1977;349-363.
19. Pai C.H., Mors V., Seemayer T.A. Experimental Yersinia enterocolitica enteritis in rabbits. Infect. Immun. 28:1980;238-244.
20. Heesemann J., Schroder J., Ulrich M. Analysis of the class-specific immune response to Yersinia enterocolitica virulence-associated antigens in oro-gastrically infected rabbits. Microb. Pathog. 5:1988;437-447.
21. Heesemann J., Gaede K., Autenrieth I.B. Experimental Yersinia enterocolitica infection in rodents: a model for human yersiniosis. APMIS. 101:1993;417-429.
22. Vesselinova A., Najdenski H., Nikolova S., Wesselinova D. Arthritis after experimental infection with Yersinia enterocolitica 0:3 in rabbits. J. Vet. Med. B. 48:(3):2001;43-53.
23. Sandlin R.C., Goldberg M.B., Maurelli A.T. Effect of O side-chain length and composition of the virulence of Shigella flexneri 2a. Mol. Microbiol. 22:1996;63-73.
24. Guard-Petter J., Parker C.T., Asokan K., Carlson R.W. Clinical and veterinary isolates of Salmonella enterica serovar enterididis defective in lipopolysaccharide O-chain polymerization. Appl. Environ. Microbiol. 65:1999;2195-2201.
25. Cover T.L., Aber R.C. Yersinia enterocolitica. New Engl. J. Med. 312:1989;16-24.
26. Berner R., Kist M., Sauer M. Encephalopathy associated with Yersinia enterocolitica O:3. Lancet. 351:1998;418.
27. Ruckdeschel K., Roggenkamp A., Schubert S., Heesemann J. Differnetial contribution of Yersinia enterocolitica virulence factors to evasion of microbicidal action of neutrophils. Infect. Immun. 64:1996;724-733.
28. Pilz D., Vocke T., Heesemann J. Mechnism of YadA-mediated serum resistance of Yersinia enterocolitica serotype O3. Infect. Immun. 60:1992;189-195.
29. Pilz D., Wachter E., Heesemann J., Brade V. Evasion of Yersinia enterocolitica serotype O3 from complement-mediated killing. Behring Inst. Mitt. 88:1991;183-193.
30. Falkow S. Bacterial entry into eukaryotic cells. Cell. 65:1991;1099-1102.
31. Sory M.-P., Hermand P., Vaerman J.P., Cornelis G.R. Oral immunization of mice with a live recombinant Yersinia enterocolitica O:9 strain that produces the cholera toxin B subunit. Infect. Immun. 58:1990;2420-2428.
32. Bowe F., O'Gaora P., Maskell D., Cafferkey M., Dougan G. Virulence, persistence, and immunogenicity of Yersinia enterocolitica O:8 aroA mutants. Infect. Immun. 57:1989;3234-3236.
33. O'Gaora P., Maskell D., Coleman D., Cafferkey M., Dougan G. Cloning and characterisation of the serC and aroA genes of Yersinia enterocolitica, and construction of an aroA mutant. Gene. 84:1989;23-30.
34. Dorell N., Li S.R., Everest P.H., Dougan G., Wren B.W. Construction and characterisation of a Yersinia enterocolitica O:8 ompR mutant. FEMS Microbiol. Lett. 165:1998;145-151.
35. Hanski C., Naumann M., Grutzkau A., Pluschke G., Friedrich B., Hahn H., Riecken E.O. Humoral and cellular defense against intestinal murine infection with Yersinia enterocolitica. Infect. Immun. 59:1991;1106-1111.
36. Heesemann J., Gaede K., Autenrieth I.B. Experimental Yersinia enterocolitica infection in rodents: a model for human yersiniosis. APMIS. 101:1993;417-429.
37. Najdenski H., Nikolova S., Vesselinova A., Nejkov P. Studies of Yersinia enterocolitica O:3 experimental infection in pigs. J. Vet. Med. B. 45:1998;59-64.